Overview

Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers

Status:
Completed

Trial end date:
2019-02-22

Target enrollment:

Participant gender:

Summary

This is a phase 1 study in healthy adult volunteers to examine the effects of 3 FDA approved medications on skin aging when applied in topical form. This is an open label, placebo controlled study.

Phase:

Phase 1

Details

Lead Sponsor:

Anne Chang

Treatments:

Diclofenac
Everolimus
Metformin
Sirolimus